Atria Investments Inc Sells 1,807 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Atria Investments Inc decreased its holdings in shares of Celsius Holdings, Inc. (NASDAQ:CELH) by 12.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,182 shares of the company’s stock after selling 1,807 shares during the quarter. Atria Investments Inc’s holdings in Celsius were worth $413,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Massachusetts Financial Services Co. MA grew its position in shares of Celsius by 231.2% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after purchasing an additional 2,754,722 shares in the last quarter. Bank of New York Mellon Corp grew its position in Celsius by 36.7% in the second quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company’s stock worth $167,983,000 after acquiring an additional 790,014 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Celsius by 0.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock worth $232,365,000 after acquiring an additional 9,054 shares in the last quarter. Capital Research Global Investors purchased a new position in Celsius in the first quarter worth $99,746,000. Finally, Dimensional Fund Advisors LP grew its position in Celsius by 86.9% in the second quarter. Dimensional Fund Advisors LP now owns 990,135 shares of the company’s stock worth $56,531,000 after acquiring an additional 460,227 shares in the last quarter. Institutional investors own 60.95% of the company’s stock.

Celsius Trading Up 4.8 %

Celsius stock opened at $29.05 on Friday. Celsius Holdings, Inc. has a 1-year low of $25.23 and a 1-year high of $99.62. The firm has a 50-day moving average of $31.05 and a 200-day moving average of $48.48. The firm has a market cap of $6.83 billion, a P/E ratio of 40.35, a P/E/G ratio of 3.13 and a beta of 1.86.

Insiders Place Their Bets

In other Celsius news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now directly owns 1,812,490 shares in the company, valued at $59,449,672. This trade represents a 3.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 2.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on CELH shares. UBS Group cut their target price on shares of Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, November 7th. Maxim Group cut their target price on shares of Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, September 5th. Stifel Nicolaus cut their target price on shares of Celsius from $51.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, November 7th. Bank of America cut their price target on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating for the company in a research report on Thursday, September 5th. Finally, Morgan Stanley restated an “equal weight” rating and set a $50.00 price target on shares of Celsius in a research report on Tuesday, August 20th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $54.40.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.